Symbols / ONMD
ONMD Chart
About
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets; and BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 32.43M |
| Enterprise Value | 32.58M | Income | -2.03M | Sales | 494.00K |
| Book/sh | -0.08 | Cash/sh | 0.00 | Dividend Yield | — |
| Payout | 0.00% | Employees | 22 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 65.66 | P/B | -8.03 | P/C | — |
| EV/EBITDA | -3.53 | EV/Sales | 65.94 | Quick Ratio | 0.15 |
| Current Ratio | 0.29 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.06 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 24.60% | Earnings | — | ROA | -197.26% |
| ROE | — | ROIC | — | Gross Margin | -140.49% |
| Oper. Margin | -12.63% | Profit Margin | 0.00% | Shs Outstand | 51.01M |
| Shs Float | 16.41M | Short Float | 0.74% | Short Ratio | 0.58 |
| Short Interest | — | 52W High | 4.22 | 52W Low | 0.30 |
| Beta | 1.14 | Avg Volume | 983.04K | Volume | 134.76K |
| Target Price | — | Recom | None | Prev Close | $0.62 |
| Price | $0.63 | Change | 2.42% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.62
Latest analyst target
3. DCF / Fair value
$1.72
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.62
Low
—
High
—
Mean
—
- EEG sleep data deal to train AI co-scientist for brain disorders - Stock Titan ue, 24 Feb 2026 13
- OneMedNet Corporation Enters Strategic Data Licensing Agreement with Risorius Co., Ltd. to Enhance Neurotechnology Research - Quiver Quantitative ue, 24 Feb 2026 14
- OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers - ChartMill ue, 24 Feb 2026 13
- A Look at OneMedNet (ONMD) Valuation Following Strategic Medcase Collaboration in Healthcare AI Data - Yahoo Finance Wed, 08 Oct 2025 07
- A Look at OneMedNet's (ONMD) Valuation Following New AI Partnerships with Palantir and Medcase - simplywall.st hu, 09 Oct 2025 07
- OneMedNet stock soars after record bookings quadruple in 2025 - Investing.com hu, 12 Feb 2026 08
- AI data firm OneMedNet quadruples 2025 deals with Palantir subscriptions - Stock Titan hu, 12 Feb 2026 08
- OneMedNet Corporation May Not Have A Competitive Product And Does Not Deserve A 200x Sales Multiple - Seeking Alpha Wed, 15 Oct 2025 07
- OneMedNet to Showcase Transformative New Platform at RSNA 2025 - GlobeNewswire Mon, 24 Nov 2025 08
- Is OneMedNet Stock Built to Withstand More Downside? - Trefis Fri, 19 Dec 2025 08
- Insider Purchase: Chief Medical Officer of $ONMD Buys 1,666,666 Shares | ONMD Stock News - Quiver Quantitative hu, 27 Nov 2025 08
- OneMedNet Teams Up With Palantir To Supercharge AI In Healthcare - Yahoo Finance Mon, 06 Oct 2025 07
- Onemednet stock soars, Palantir shares rise on AI healthcare partnership - Investing.com Mon, 06 Oct 2025 07
- $ONMD stock is up 23% today. Here's what we see in our data. - Quiver Quantitative Fri, 28 Nov 2025 08
- OneMedNet (Nasdaq: ONMD) Grows RWD Network 38% as Subscription Model Scales - Stock Titan hu, 20 Nov 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 547605 | — | — | Stock Award(Grant) at price 0.00 per share. | GOLDEN ROBERT LAWRENCE | Chief Financial Officer | — | 2025-11-26 00:00:00 | D |
| 1 | 138485 | — | — | Stock Award(Grant) at price 0.00 per share. | CLARKE JAIR | Director | — | 2025-11-26 00:00:00 | D |
| 2 | 90000 | — | — | Stock Award(Grant) at price 0.00 per share. | KOSASA THOMAS | Director | — | 2025-11-26 00:00:00 | D |
| 3 | 245000 | — | — | Stock Award(Grant) at price 0.00 per share. | YU JEFFREY | Officer and Director | — | 2025-11-26 00:00:00 | D |
| 4 | 90000 | — | — | Stock Award(Grant) at price 0.00 per share. | CASABURI ERIC | Director | — | 2025-11-26 00:00:00 | D |
| 5 | 1090000 | — | — | Stock Award(Grant) at price 0.00 per share. | GREEN AARON | Chief Executive Officer | — | 2025-11-26 00:00:00 | D |
| 6 | 144403 | — | — | Stock Award(Grant) at price 0.00 per share. | ZEINFELD ANDREW B. | Director | — | 2025-11-26 00:00:00 | D |
| 7 | 56342 | — | — | Stock Award(Grant) at price 0.00 per share. | MCCRAW SHERRY COONSE | Director | — | 2025-11-26 00:00:00 | D |
| 8 | 38219 | — | — | Stock Award(Grant) at price 0.00 per share. | ALLEYNE KENNETH | Director | — | 2025-11-26 00:00:00 | D |
| 9 | 126322 | 218625 | — | Sale at price 1.20 - 2.23 per share. | GREEN AARON | Chief Executive Officer | — | 2025-11-18 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | -1.91M | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.21 | 0.21 | 0.00 |
| NormalizedEBITDA | -10.38M | -24.64M | -30.41M | -2.73M |
| TotalUnusualItems | 458.00K | -9.08M | 4.49M | |
| TotalUnusualItemsExcludingGoodwill | 458.00K | -9.08M | 4.49M | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -10.13M | -33.78M | -30.45M | -2.94M |
| ReconciledDepreciation | 57.00K | 28.00K | 25.00K | 14.47K |
| ReconciledCostOfRevenue | 924.00K | 1.15M | 1.51M | 1.21M |
| EBITDA | -9.92M | -33.72M | -30.41M | -2.73M |
| EBIT | -9.98M | -33.75M | -30.43M | -2.75M |
| NetInterestIncome | -147.00K | -11.00K | 0.00 | -195.38K |
| InterestExpense | 147.00K | 11.00K | 0.00 | 195.38K |
| NormalizedIncome | -10.59M | -26.61M | -30.45M | -2.94M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -10.13M | -33.78M | -30.45M | -2.94M |
| TotalExpenses | 10.25M | 7.87M | 16.94M | 3.80M |
| TotalOperatingIncomeAsReported | -9.61M | -6.85M | -7.71M | -2.71M |
| DilutedAverageShares | 28.08M | 7.27M | 4.03M | 4.03M |
| BasicAverageShares | 28.08M | 7.27M | 4.03M | 4.03M |
| DilutedEPS | -0.36 | -4.65 | -7.55 | -0.73 |
| BasicEPS | -0.36 | -4.65 | -7.55 | -0.73 |
| DilutedNIAvailtoComStockholders | -10.13M | -33.78M | -30.45M | -2.94M |
| NetIncomeCommonStockholders | -10.13M | -33.78M | -30.45M | -2.94M |
| NetIncome | -10.13M | -33.78M | -30.45M | -2.94M |
| NetIncomeIncludingNoncontrollingInterests | -10.13M | -33.78M | -30.45M | -2.94M |
| NetIncomeContinuousOperations | -10.13M | -33.78M | -30.45M | -2.94M |
| TaxProvision | 2.00K | 18.00K | 17.00K | |
| PretaxIncome | -10.13M | -33.76M | -30.43M | -2.94M |
| OtherIncomeExpense | -375.00K | -26.90M | -14.65M | -34.91K |
| OtherNonOperatingIncomeExpenses | -833.00K | -17.82M | -14.65M | -34.91K |
| SpecialIncomeCharges | -10.50M | |||
| WriteOff | 10.50M | |||
| GainOnSaleOfSecurity | 458.00K | -9.08M | 4.49M | |
| NetNonOperatingInterestIncomeExpense | -147.00K | -11.00K | 0.00 | -195.38K |
| InterestExpenseNonOperating | 147.00K | 11.00K | 0.00 | 195.38K |
| OperatingIncome | -9.61M | -6.85M | -15.79M | -2.71M |
| OperatingExpense | 9.32M | 6.72M | 15.43M | 2.60M |
| OtherOperatingExpenses | 226.26K | 398.76K | 152.46K | |
| ResearchAndDevelopment | 1.47M | 2.06M | 1.59M | 642.76K |
| SellingGeneralAndAdministration | 7.86M | 4.66M | 13.84M | 1.80M |
| SellingAndMarketingExpense | 830.00K | 1.11M | 958.00K | 605.24K |
| GeneralAndAdministrativeExpense | 7.03M | 3.54M | 12.88M | 1.20M |
| OtherGandA | 7.03M | 3.54M | 4.81M | 1.20M |
| SalariesAndWages | 3.57M | 8.07M | ||
| GrossProfit | -281.00K | -129.00K | -360.00K | -113.41K |
| CostOfRevenue | 924.00K | 1.15M | 1.51M | 1.21M |
| TotalRevenue | 643.00K | 1.02M | 1.15M | 1.09M |
| OperatingRevenue | 643.00K | 1.02M | 1.15M | 1.09M |
| Line Item | 2024-12-31 | 2023-12-31 | ||
|---|---|---|---|---|
| TreasurySharesNumber | 187.75K | 0.00 | ||
| OrdinarySharesNumber | 27.99M | 23.57M | 32.26M | 32.26M |
| ShareIssued | 28.18M | 23.57M | 32.26M | 32.26M |
| NetDebt | 8.59M | 5.05M | 25.97M | 4.20M |
| TotalDebt | 8.76M | 5.09M | 26.24M | 4.90M |
| TangibleBookValue | -15.95M | -13.44M | -44.00M | -5.70M |
| InvestedCapital | -7.19M | -8.35M | -17.76M | -806.42K |
| WorkingCapital | -15.61M | -13.47M | -25.71M | -3.92M |
| NetTangibleAssets | -15.95M | -13.44M | -26.36M | -5.70M |
| CommonStockEquity | -15.95M | -13.44M | -44.00M | -5.70M |
| PreferredStockEquity | 17.64M | 705.00 | ||
| TotalCapitalization | -15.95M | -13.44M | -24.86M | -4.16M |
| TotalEquityGrossMinorityInterest | -15.95M | -13.44M | -26.36M | -5.70M |
| StockholdersEquity | -15.95M | -13.44M | -26.36M | -5.70M |
| OtherEquityInterest | 28.75M | |||
| TreasuryStock | 529.00K | 0.00 | ||
| RetainedEarnings | -101.57M | -91.44M | -57.66M | -25.31M |
| AdditionalPaidInCapital | 86.15M | 78.00M | 13.66M | 19.61M |
| CapitalStock | 2.00K | 2.00K | 17.64M | 1.14K |
| CommonStock | 2.00K | 2.00K | 0.00 | 434.00 |
| PreferredStock | 0.00 | 0.00 | 17.64M | 705.00 |
| TotalLiabilitiesNetMinorityInterest | 19.68M | 13.91M | 27.65M | 6.59M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 449.00K | 68.00K | 1.54M | 1.83M |
| OtherNonCurrentLiabilities | 449.00K | 68.00K | 44.00K | |
| DerivativeProductLiabilities | 24.58K | 362.56K | ||
| NonCurrentAccruedExpenses | 690.77K | 287.61K | ||
| TradeandOtherPayablesNonCurrent | 0.00 | 4.03M | ||
| LongTermDebtAndCapitalLeaseObligation | 465.00K | 1.50M | 1.55M | |
| LongTermDebt | 465.00K | 1.50M | 1.55M | |
| CurrentLiabilities | 19.23M | 13.84M | 26.10M | 4.75M |
| OtherCurrentLiabilities | 283.00K | 283.00K | ||
| CurrentDeferredLiabilities | 561.00K | 254.00K | 184.00K | 642.35K |
| CurrentDeferredRevenue | 561.00K | 254.00K | 184.00K | 642.35K |
| CurrentDebtAndCapitalLeaseObligation | 8.76M | 5.09M | 24.74M | 3.35M |
| CurrentDebt | 8.76M | 5.09M | 24.74M | 3.35M |
| OtherCurrentBorrowings | 5.31M | 3.46M | 24.74M | 3.35M |
| CurrentNotesPayable | 3.45M | 1.64M | 0.00 | |
| PayablesAndAccruedExpenses | 9.62M | 8.21M | 1.18M | 758.82K |
| Payables | 9.62M | 8.21M | 1.18M | |
| OtherPayable | 3.25M | 3.52M | ||
| TotalTaxPayable | 233.37K | 284.82K | ||
| IncomeTaxPayable | 120.02K | 214.85K | ||
| AccountsPayable | 6.37M | 4.68M | 1.18M | |
| TotalAssets | 3.73M | 464.00K | 1.29M | 883.06K |
| TotalNonCurrentAssets | 108.00K | 99.00K | 898.00K | 49.77K |
| NonCurrentDeferredAssets | 0.00 | 815.00K | ||
| NetPPE | 108.00K | 99.00K | 83.00K | 49.77K |
| AccumulatedDepreciation | -216.00K | -208.00K | -180.00K | -156.79K |
| GrossPPE | 324.00K | 307.00K | 263.00K | 206.56K |
| MachineryFurnitureEquipment | 324.00K | 307.00K | 263.00K | 206.56K |
| CurrentAssets | 3.62M | 365.00K | 391.00K | 833.29K |
| OtherCurrentAssets | 385.00K | 166.00K | 101.00K | 42.23K |
| RestrictedCash | 0.00 | 29.03M | ||
| Receivables | 213.00K | 152.00K | 19.00K | 91.74K |
| DuefromRelatedPartiesCurrent | 900.15K | 0.00 | ||
| AccountsReceivable | 213.00K | 152.00K | 19.00K | 91.74K |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | 0.00 | -125.23K | |
| GrossAccountsReceivable | 213.00K | 152.00K | 144.23K | |
| CashCashEquivalentsAndShortTermInvestments | 3.02M | 47.00K | 271.00K | 699.32K |
| OtherShortTermInvestments | 2.85M | 0.00 | ||
| CashAndCashEquivalents | 172.00K | 47.00K | 271.00K | 699.32K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -7.03M | -4.83M | -4.76M | -1.87M |
| RepurchaseOfCapitalStock | -200.00K | 0.00 | -88.55M | |
| RepaymentOfDebt | -730.00K | 0.00 | -2.75K | |
| IssuanceOfDebt | 3.85M | 6.13M | 5.14M | 2.49M |
| IssuanceOfCapitalStock | 6.27M | 16.00K | 0.00 | |
| CapitalExpenditure | -51.00K | -44.00K | -58.00K | -29.94K |
| InterestPaidSupplementalData | 26.00K | 0.00 | ||
| IncomeTaxPaidSupplementalData | 18.00K | 0.00 | ||
| EndCashPosition | 172.00K | 47.00K | 271.00K | 699.32K |
| BeginningCashPosition | 47.00K | 271.00K | 699.00K | 79.18K |
| ChangesInCash | 125.00K | -224.00K | -428.00K | 620.14K |
| FinancingCashFlow | 9.09M | 4.61M | 4.33M | 2.49M |
| CashFlowFromContinuingFinancingActivities | 9.09M | 4.61M | 4.33M | 2.49M |
| NetOtherFinancingCharges | -100.00K | -1.53M | -815.00K | |
| ProceedsFromStockOptionExercised | 0.00 | 8.00K | ||
| NetPreferredStockIssuance | 0.00 | 16.00K | 0.00 | |
| PreferredStockIssuance | 0.00 | 16.00K | 0.00 | |
| NetCommonStockIssuance | 6.07M | 0.00 | -85.72M | |
| CommonStockPayments | -200.00K | 0.00 | -88.55M | |
| CommonStockIssuance | 6.27M | 0.00 | 2.83M | |
| NetIssuancePaymentsOfDebt | 3.12M | 6.13M | 5.14M | 2.49M |
| NetShortTermDebtIssuance | 3.12M | 6.13M | ||
| ShortTermDebtPayments | -730.00K | 0.00 | ||
| ShortTermDebtIssuance | 3.85M | 6.13M | ||
| NetLongTermDebtIssuance | -8.67M | 5.14M | 2.49M | |
| LongTermDebtPayments | -10.68M | -2.75K | ||
| LongTermDebtIssuance | 2.02M | 5.14M | 2.49M | |
| InvestingCashFlow | -1.98M | -44.00K | -58.00K | -29.94K |
| CashFlowFromContinuingInvestingActivities | -1.98M | -44.00K | -58.00K | -29.94K |
| NetInvestmentPurchaseAndSale | -1.93M | 0.00 | ||
| SaleOfInvestment | 969.00K | 0.00 | ||
| PurchaseOfInvestment | -2.90M | 0.00 | ||
| NetPPEPurchaseAndSale | -51.00K | -44.00K | -58.00K | -29.94K |
| PurchaseOfPPE | -51.00K | -44.00K | -58.00K | -29.94K |
| OperatingCashFlow | -6.98M | -4.79M | -4.70M | -1.84M |
| CashFlowFromContinuingOperatingActivities | -6.98M | -4.79M | -4.70M | -1.84M |
| ChangeInWorkingCapital | 1.50M | 611.00K | -29.00K | 984.13K |
| ChangeInOtherWorkingCapital | 307.00K | 70.00K | -458.00K | 558.51K |
| ChangeInOtherCurrentAssets | 0.00 | -958.87K | -23.16K | |
| ChangeInPayablesAndAccruedExpense | 1.49M | 717.00K | 415.00K | 367.70K |
| ChangeInPayable | 1.49M | 717.00K | 2.06M | |
| ChangeInAccountPayable | 1.49M | 717.00K | 1.93M | |
| ChangeInTaxPayable | -51.45K | 120.81K | ||
| ChangeInIncomeTaxPayable | -51.45K | 120.81K | ||
| ChangeInPrepaidAssets | -234.00K | -43.00K | -59.00K | |
| ChangeInReceivables | -61.00K | -133.00K | 73.00K | 81.09K |
| ChangesInAccountReceivables | -61.00K | -133.00K | 73.00K | 81.09K |
| OtherNonCashItems | 1.43M | 17.80M | 15.81M | |
| StockBasedCompensation | 628.00K | 1.48M | 1.86M | 97.87K |
| UnrealizedGainLossOnInvestmentSecurities | -798.00K | 0.00 | 14.62M | |
| DepreciationAmortizationDepletion | 57.00K | 28.00K | 25.00K | 14.47K |
| DepreciationAndAmortization | 57.00K | 28.00K | 25.00K | 14.47K |
| OperatingGainsLosses | 325.00K | 9.08M | 8.07M | |
| GainLossOnInvestmentSecurities | 340.00K | 9.08M | 8.07M | |
| NetIncomeFromContinuingOperations | -10.13M | -33.78M | -30.45M | -2.94M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ONMD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|